Rare causes of hereditary iron overload

Seminars in Hematology

Volumn 39, Issue 4, 2002, Pages 249-262

  Ponka, Prem ^a  

^a MCGILL UNIVERSITY   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

FRATAXIN; HEME OXYGENASE 1; IRON; IRON REGULATORY FACTOR; OXYGEN RADICAL; TRANSFERRIN; TRANSFERRIN RECEPTOR; IRON BINDING PROTEIN; TFR2 PROTEIN, HUMAN;

ALLELE; ANEMIA; ATAXIA; BRADYKINESIA; CARBOXY TERMINAL SEQUENCE; DEGENERATIVE DISEASE; FRIEDREICH ATAXIA; GENE DISRUPTION; GLOBUS PALLIDUS; HALLERVORDEN SPATZ DISEASE; HEMOCHROMATOSIS; HUMAN; IRON METABOLISM; IRON OVERLOAD; IRON STORAGE; IRON TRANSPORT; MOTOR DYSFUNCTION; MUTATION; OXIDATIVE STRESS; PHENOTYPE; PRIORITY JOURNAL; REVIEW; TRANSFERRIN BLOOD LEVEL; TREMOR; ANIMAL; CLASSIFICATION; DEMYELINATING DISEASE; DISORDERS OF METAL METABOLISM; FAMILY HEALTH; GENETICS; METABOLISM;

ANIMALS; FAMILY HEALTH; HEMOCHROMATOSIS; HEREDODEGENERATIVE DISORDERS, NERVOUS SYSTEM; HUMANS; IRON OVERLOAD; IRON-BINDING PROTEINS; METAL METABOLISM, INBORN ERRORS; MUTATION; RECEPTORS, TRANSFERRIN;

EID: 0036800650     PISSN: 00371963     EISSN: None     Source Type: Journal    
DOI: 10.1053/shem.2002.35638     Document Type: Article

References (77)

1. Aardon O, Kaplan J, Martin BD: Iron uptake in yeast, in Templeton DM (ed): Molecular and Cellular Iron Transport. New York, NY, Dekker, 2002, pp 375-393
2. Abboud S, Haile DJ: A novel mammalian iron-regulated protein involved in intracellular iron metabolism. J Biol Chem 275:19906-19912, 2000
3. Aisen P, Enns C, Wessling-Resnick M: Chemistry and biology of eukaryotic iron metabolism. Int J Biochem Cell Biol 33: 940-949, 2001
4. Andrews NC: Iron homeostasis: Insights from genetics and animal models. Nat Rev Genet 1:208-217, 2000
5. Asada-Senju M, Maeda T, Sakata T: Molecular analysis of the transferrin gene in a patient with hereditary hypotransferrinemia. J Hum Genet 47:355-359, 2002
6. Babcock M, de Silva D, Oaks R, et al: Regulation of mitochondrial iron accumulation by Yfh1p, a putative homolog of frataxin. Science 276:1709-1712, 1997
7. Baranano DE, Wolosker H, Bae BI, et al: A mammalian iron ATPase induced by iron. J Biol Chem 275:15166-15173, 2000
8. Becker EM, Greer HM, Ponka P, et al: Erythroid differentiation and protoporphyrin IX down-regulate frataxin expression in Friend cells: Characterization of frataxin expression compared to molecules involved in iron metabolism and hemoglobinization. Blood 99:3813-3822, 2002
9. Becker E, Richardson DR: Frataxin: Its role in iron metabolism and the pathogenesis of Friedreich's ataxia. Int J Biochem Cell Biol 33:1-10, 2001
10. Beaumont C, Girelli D: Hereditary hyperferritinemia cataract syndrome, in Templeton DM (ed): Molecular and Cellular Iron Transport. New York, NY, Dekker, 2002, pp 761-774
11. Beaumont C, Leneuve P, Devaux I, et al: Mutation in the iron responsive element of the L ferritin mRNA in a family with dominant hyperferritinaemia and cataract. Nat Genet 11:444-446, 1995
12. Bernstein SE: Hereditary hypotransferrinemia with hemosiderosis, a murine disorder resembling human atransferrinemia. J Lab Clin Med 110:690-705, 1987
13. Beutler E, Gelbart T, Lee P, et al: Molecular characterization of a case of atransferrinemia. Blood 96:4071-4074, 2000
14. Brooks DG, Manova-Todorova K, Farmer J, et al: Ferritin crystal cataracts in hereditary hyperferritinemia cataract syndrome. Invest Ophthalmol Vis Sci 43:1121-1126, 2002
15. Bulaj ZJ, Ajioka RS, Phillips JD, et al: Disease-related conditions in relatives of patients with hemochromatosis. N Engl J Med 343:1529-1535, 2000
16. Buys SS, Martin CB, Eldridge M, et al: Iron absorption in hypotransferrinemic mice. Blood 78:3288-3290, 1991
17. Camaschella C, Roetto A, Cali A, et al: The gene encoding transferrin receptor 2 is mutated in a new type of hemochromatosis mapping to 7q22. Nat Genet 25:14-15, 2000
18. Čáp J, Lehotská V, Mayerová A: Kongenitálná atransferinemia u 11-mesačného dietata. Česk Pediat 23:1020-1025, 1968
19. Curtis AR, Fey C, Morris CM, et al: Mutation in the gene encoding ferritin light polypeptide causes dominant adultonset basal ganglia disease. Nat Genet 28:350-354, 2001
20. De Gobbi M, Barilaro MR, Garozzo G, et al: TFR2 Y250X mutations in Italy. Br J Haematol 114:241-242, 2001
21. Devalia V, Carter K, Walker AP, et al: Autosomal dominant reticulo-endothelial iron overload associated with a three base pair deletion in the ferroportin 1 gene (SLC11A3). Blood 100:695-697, 2002
22. Dickinson TK, Connor JR: Histological analysis of selected brain regions of hypotransferrinemic mice. Brain Res 635: 169-178, 1994
23. Djeha A, Perez-Arellano JL, Hayes SL, et al: Transferrin synthesis by macrophages: Up-regulation by gamma-interferon and effect on lymphocyte proliferation. FEMS Microbiol Immunol 5:279-282, 1992
24. Donovan A, Brownlie A, Zhou Y, et al: Positional cloning of zebrafish ferroportin 1 identifies a conserved vertebrate iron exporter. Nature 403:776-781, 2000
25. Ferreira C, Bucchini D, Martin ME, et al: Early embryonic lethality of H ferritin gene deletion in mice. J Biol Chem 275:3021-3024, 2000
26. Ferreira C, Santambrogio P, Martin ME, et al: H ferritin knockout mice: A model of hyperferritinemia in the absence of iron overload. Blood 98:525-532, 2001
27. Fleming MD, Trenor CC 3rd, Su MA, et al: Microcytic anaemia mice have a mutation in Nramp2, a candidate iron transporter gene. Nat Genet 16:383-386, 1997
28. Fleming MD, Romano MA, Su MA, et al: Nramp2 is mutated in the anemic Belgrade (b) rat: Evidence of a role for Nramp2 in endosomal iron transport. Proc Natl Acad Sci USA 95: 1148-1153, 1998
29. Fleming RE, Sly WA: Ferroportin mutation in autosomal dominant hemochromatosis: Loss of function, gain in understanding. J Clin Invest 108:521-522, 2001
30. a.Fleming RE, Ahmann JR, Migas MC, et al: Targeted mutagenesis of the murine transferrin receptor-2 gene produces hemochromatosis. Proc Natl Acad Sci USA 99:10653-10658, 2002
31. Girelli D, Bozzini C, Roetto A, et al: Clinical and pathologic findings in hemochromatosis type 3 due to a novel mutation in transferrin receptor 2 gene. Gastroenterology 122:1295-1302, 2002
32. Goldwurm S, Casati C, Venturi N, et al: Biochemical and genetic defects underlying human congenital hypotransferrinemia. Hematol J 1:390-398, 2000
33. Goya N, Myazaki S, Kodate S, et al: A family of congenital atransferrinemia. Blood 40:239-245, 1972
34. Griffiths WJH, Cox TM: Transferrin receptor 2 interacts with HFE and is implicated in crypt cell iron signaling. Presented at Bioiron 2001 - World Congress on Iron Metabolism, Cairns, Australia, August 18-23, 2001
35. Hamill RL, Woods JC, Cook BA: Congenital atransferrinemia: A case report and review of the literature. Am J Clin Pathol 96:215-218, 1991
36. Harris ZL, Durley AP, Man TK, et al: Targeted gene disruption reveals an essential role for ceruloplasmin in cellular iron efflux. Proc Natl Acad Sci USA 96:10812-10817, 1999
37. Harrison PM, Arosio P: The ferritins: Molecular properties, iron storage function and cellular regulation. Biochim Biophys Acta 1275:161-203, 1996
38. Heilmayer L, Keller W, Vivell O, et al: Kongenitale Atransferinämie bei einem sieben Jahre alten Kind. Dtsch Med Wochenschr 86:1745-1751, 1961
39. Huggenvik JI, Craven CM, Idzerda RL, et al: A splicing defect in the mouse transferrin gene leads to congenital atransferrinemia. Blood 74:482-486, 1989
40. Kato J, Fujikawa K, Kanda M, et al: A mutation, in the iron-responsive element of H ferritin mRNA, causing autosomal dominant iron overload. Am J Hum Genet 69:191-197, 2001
41. Kawabata H, Yang R, Hirama T, et al: Molecular cloning of transferrin receptor 2. A new member of the transferrin receptor-like family. J Biol Chem 274:20826-20832, 1999
42. Kawashima A, Oda Y, Yachie A, et al: Heme oxygenase-1 deficiency: The first autopsy case. Hum Pathol 33:125-130, 2002
43. Kim S, Ponka P: Nitrogen monoxide-mediated control of ferritin synthesis: Implications for macrophage iron homeostasis. Proc Natl Acad Sci USA 99:12214-12219, 2002
44. Kondo H, Saito K, Grasso JP, et al: Iron metabolism in the erythrophagocytosing Kupffer cell. Hepatology 8:32-38, 1988
45. Lamarche JB, Cote M, Lemieux B: The cardiomyopathy of Friedreich's ataxia morphological observations in 3 cases. Can J Neurol Sci 7:389-396, 1980
46. LaVaute T, Smith S, Cooperman, S, et al: Targeted deletion of the gene encoding iron regulatory protein-2 causes misregulation of iron metabolism and neurodegenerative disease in mice. Nat Genet 27:209-214, 2001
47. Lee PL, Halloran C, West C, et al: Mutation analysis of the transferrin receptor-2 gene in patients with iron overload. Blood Cells Mol Dis 27:285-289, 2001
48. Levy JE, Jin O, Fujiwara Y, et al: Transferrin receptor is necessary for development of erythrocytes and the nervous system. Nat Genet 21:396-399, 1999
49. MacGillivray RTA, Mason AB: Transferrins, in Templeton DM (ed): Molecular and Cellular Iron Transport. New York, NY, Dekker, 2002, pp 41-69
50. Maines MD: The heme oxygenase system: A regulator of second messenger gases. Annu Rev Pharmacol Toxicol 37: 517-554, 1997
51. Mattman A, Huntsman D, Lockitch G, et al: Transferrin receptor 2 (TfR2) and HFE mutational analysis in non-C282Y iron overload: Identification of a novel TfR2 mutation. Blood 100:1075-1077, 2002
52. McKie AT, Marciani P, Rolfs A, et al: A novel duodenal iron-regulated transporter, 1REG1, implicated in the basolateral transfer of iron to the circulation. Mol Cell 5:299-309, 2000
53. Montosi G, Donovan A, Totaro A, et al: Autosomal-dominant hemochromatosis is associated with a mutation in the ferroportin (SLC11A3) gene. J Clin Invest 108:619-623, 2001
54. Njajou OT, Vaessen N, Joosse M, et al: A mutation in SLC11A3 is associated with autosomal dominant hemochromatosis. Nat Genet 28:213-214, 2001
55. Pandolfo M: Molecular pathogenesis of Friedreich ataxia. Arch Neurol 56:1201-1208, 1999
56. Perry TL, Norman MG, Yong VW, et al: Hallervorden-Spatz disease: Cysteine accumulation and cysteine dioxygenase deficiency in the globus pallidus. Ann Neurol 18:482-489, 1985
57. Ponka P: Tissue-specific regulation of iron metabolism and heme synthesis: Distinct control mechanisms in erythroid cells. Blood 89:1-25, 1997
58. Ponka P, Beaumont C, Richardson DR: Function and regulation of transferrin and ferritin. Semin Hematol 35:35-54, 1998
59. Ponka P, Lok CN: The transferrin receptor: Role in health and disease. Int J Biochem Cell Biol 31:1111-1137, 1999
60. Poss KD, Tonegawa S: Heme oxygenase 1 is required for mammalian iron reutilization. Proc Natl Acad Sci USA 94: 10919-10924, 1997
61. Poss KD, Tonegawa S: Reduced stress defense in heme oxygenase 1-deficient cells. Proc Natl Acad Sci USA 94:10925-10930, 1997
62. Puccio H, Simon D, Cossee M, et al: Mouse models for Friedreich ataxia exhibit cardiomyopathy, sensory nerve defect and Fe-S enzyme deficiency followed by intramitochondrial iron deposits. Nat Genet 27:181-186, 2001
63. Radisky DC, Babcock MC, Kaplan J: The yeast frataxin homologue mediates mitochondrial iron efflux. Evidence for a mitochondrial iron cycle. J Biol Chem 274:4497-4499, 1999
64. Raja KB, Pountney DJ, Simpson RJ, et al: Importance of anemia and transferrin levels in the regulation of intestinal iron absorption in hypotransferrinemic mice. Blood 94:3185-3192, 1999
65. Richardson DR, Ponka P: The molecular mechanisms of the metabolism and transport of iron in normal and neoplastic cells. Biochim Biophys Acta 1331:1-40, 1997
66. Roetto A, Totaro A, Piperno A, et al: New mutations inactivating transferrin receptor 2 in hemochromatosis type 3. Blood 97:2555-2560, 2001
67. Rouault TA: Iron on the brain. Nat Genet 28:299-300, 2001
68. Rouault T, Klausner R: Regulation of iron metabolism in eukaryotes. Curr Top Cell Regul 35:1-19, 1997
69. Sanchez-Casis G, Cote M, Barbeau A: Pathology of the heart in Friedreich's ataxia: Review of the literature and report of one case. Can J Neurol Sci 3:349-354, 1976
70. Simpson RJ, Lombard M, Raja KB, et al: Iron absorption by hypotransferrinaemic mice. Br J Haematol 78:565-570, 1991
71. Swaiman KF: Hallervorden-Spatz syndrome. Pediatr Neurol 25:102-108, 2001
72. Trenor CC III, Campagna DR, Sellers VM, et al: The molecular defect in hypotransferrinemic mice. Blood 96:1113-1118, 2000
73. Vulpe CD, Kuo YM, Murphy TL, et al: Hephaestin, a ceruloplasmin homologue implicated in intestinal iron transport, is defective in the sla mouse. Nat Genet 21:195-199, 1999
74. Wallace DF, Pedersen P, Dixon JL, et al: Novel mutation in ferroportin 1 is associated with autosomal dominant hemochromatosis. Blood 100:692-694, 2002
75. West AP Jr, Bennett MJ, Sellers VM, et al: Comparison of the interactions of transferrin receptor and transferrin receptor 2 with transferrin and the hereditary hemochromatosis protein HFE. J Biol Chem 275:38135-38138, 2000
76. Yachie A, Niida Y, Wada T, et al: Oxidative stress causes enhanced endothelial cell injury in human heme oxygenase-1 deficiency. J Clin Invest 103:129-135, 1999
77. Zhou B, Westaway SK, Levinson B, et al: A novel pantothenate kinase gene (PANK2) is defective in Hallervorden-Spatz syndrome. Nat Genet 28:345-349, 2001